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Abstract
Background: Cochrane reviews are regarded as being scientifically rigorous and are increasingly used by a variety of
stakeholders. However, factors predicting the publication of Cochrane reviews have never been reported. This is important
because if a higher proportion of Cochrane protocols with certain characteristics (e.g., funding) are being published, this
may lead to inaccurate decisions. We examined the frequency of published and unpublished Cochrane reviews and protocol
factors that predict the publication of Cochrane reviews.
Methodology/Principal Findings: Retrospective cohort study of Cochrane protocols published in 2000 (Issues 2 to 4) and
2001 (Issue 1). The publication status of these reviews was followed up to Issue 1, 2008 in The Cochrane Library. Survival
analysis of the time from protocol publication to the first review publication and protocol factors predicting the time to
publication was conducted. There were 411 new Cochrane protocols in the cohort. After excluding 39; 71/372 (19.1%) were
unpublished and 301/372 (80.9%) were published as full Cochrane reviews at the time of study analysis (January 2008). The
median time to publication was 2.4 years (range: 0.15 to 8.96). Multivariate analyses revealed that shorter time to
publication was associated with the review subsequently being updated (hazard ratio, HR: 1.80 [95% confidence interval, CI:
1.39 to 2.33 years]) and longer time to publication was associated with the review having two published protocols,
indicating changes to the review plan (HR: 0.33 [95% CI: 0.12 to 0.90 years]).
Conclusions/Significance: Only about 80% Cochrane protocols were published as full reviews after over 8 years of follow-
up. The median time to publication was 2.4 years and some reviews took much longer. Strategies to decrease time to
publication should be considered, such as streamlining the review process, increased support for authors when protocol
amendments occur, and better infrastructure for updating Cochrane reviews.
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Introduction
The mission of the Cochrane Collaboration is to conduct
systematic reviews in all areas of healthcare [1]. Currently, the
Collaboration includes more than 10,000 members globally
organized into clinical review groups (CRGs; e.g., schizophrenia
group), methods groups (e.g., bias methods group), and fields (e.g.,
child health field) [1]. Evidence suggests that Cochrane reviews are
the most scientifically reported systematic reviews [2]. They are
also increasingly being used by consumers, clinicians, and policy-
makers as part of their decision-making process [3]. Although
these reviews are highly regarded, their frequency of publication
and factors associated with their publication remains unknown. If
factors such as funding are associated with subsequent publication
this may imply that Cochrane reviews are also subject to
publication bias.
Publication bias occurs when ‘‘investigators, reviewers, and
editors submit or accept manuscripts for publication based on the
direction or strength of the study findings’’[4]. Publication bias
also occurs when studies with certain characteristics (e.g.,
favourable results, funding from organizations with vested
interests, such as pharmaceutical companies or the tobacco
industry) are published quicker than those without these
characteristics [5]. Publication bias has been extensively examined
for individual studies (e.g., randomized trials) [4,6–11], but is
under-explored for systematic reviews [12–14].
Cochrane reviews can be followed over time to examine
whether certain factors are associated with their publication. The
process for publishing a Cochrane review includes the following: 1)
title (or topic) registration to ensure that the review is unique to
The Cochrane Library, 2) publication of a protocol, which outlines
the review plan, 3) conduct of the review, 4) publication of the
review report, and 5) update of the review, which usually occurs
every two years [1]. Cochrane reviews can be published elsewhere,
yet they should be published in The Cochrane Library first. All
Cochrane protocols and their respective reviews are provided with
a unique Cochrane identification number, which allows both to be
followed over time. We conducted a retrospective cohort study to
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3684examine the frequency of published and unpublished Cochrane
reviews and determine the protocol factors that predict the
publication of Cochrane reviews.
Methods
Cohort sample acquisition
A new issue of The Cochrane Library is published quarterly
along with a CD with all of its contents. We obtained all Cochrane
Library CDs from inception from the UK Cochrane Centre and
Canadian Cochrane Network and Centre. In order to allow time
for publication, we selected all new protocols from 2000 (Issues 2
to 4) and 2001 (Issue 1) [4,8–11]. The CD indicates when a
Cochrane protocol is new to that particular issue.
The unique Cochrane identification number was entered into
Issue 1, 2008 of The Cochrane Library to determine the
publication status. Authors of Cochrane protocols that could no
longer be found in The Cochrane Library were contacted for
further information. When a response from the authors was not
received, the CRG coordinator responsible for the Cochrane
protocol was contacted.
The new protocols arising from the Cochrane CDs were
subsequently screened to ensure that they were eligible for the
study. Cochrane protocols that were split into more than one
Cochrane review, taken over by another review group, published
in the same issue as the corresponding Cochrane review itself,
published later than the review publication or published prior to
Issue 2, 2000 were excluded.
Data abstraction
A 37-item data abstraction form was developed by two
investigators (ACT, DM) and pilot-tested. Descriptive characteris-
tics (country of conduct, population examined, number of authors,
number of protocols [multiple protocols indicating that changes to
the original review plan occurred], number of unique Cochrane
identificationnumbers[someofthe reviewshad multiplenumbers]),
planned methodology (observational versus experimental study
inclusion, number of databases searched, number of primary
outcomes, inclusion of unpublished material, language inclusion,
assessment of publication bias, assessment of heterogeneity), and
other characteristics (gender of corresponding author and whether
they were a healthcare provider, number of updates, funding) were
abstracted from the Cochrane protocols by one investigator (ACT).
Data were also abstracted from the original version of the Cochrane
review, such as the timing of publication and whether it was
subsequently updated. Random data checks were made by two
investigators, independently (ACT, MHC).
Two time points were abstracted for the analysis from all
included protocols and their subsequent reviews. The first was the
version first published online date of publication from The Cochrane
Library citation and the second was the most recent substantive
amendment date from the cover page of the Cochrane protocol and
associated completed review. As Cochrane reviews are published
quarterly, the version first published online date is truncated to four
time points per year. As such, it was decided that the most recent
substantive amendment date would be used for the primary analyses
while the version first published online date would be used for sensitivity
analyses. The most recent substantive amendment date always
occurs prior to the publication date, resulting in more than eight
years of follow-up data.
Data analysis
Time-to-publication analyses were conducted using the Kaplan-
Meier method, which is often used to estimate time-related events
and takes into account censored data (i.e., losses to the sample that
occur prior to the final outcome) [15]. Cochrane reviews that
remained unpublished at the time of study were censored on
January 23, 2008 (i.e., the publication date of Cochrane Library,
Issue 1, 2008). Cox proportional hazards models (regression
models often used to examine time-dependent factors) were then
used to predict the time to publication of Cochrane reviews.
Hazard ratios and 95% confidence intervals were calculated. The
hazard ratio is the effect of an explanatory variable on the hazard
or risk of an event and can be thought of as an estimate of the
relative risk (i.e., the risk of an event, in this case the risk of being
unpublished, relative to exposure, such as, lack of funding,
negative results). Variables chosen for the univariate and
multivariate analyses were based on a priori consideration of most
plausible predictors for time to publication. Both univariate and
multivariate models and interactions between variables were
assessed. Statistical analyses were conducted with SAS, version
9.0 (SAS Institute, Cary, North Carolina). This analysis is
consistent with research on the publication status of individual
studies (e.g., randomized trials) [4,8–11], providing the opportu-
nity to compare our results with these studies.
Results
Frequency of published Cochrane reviews
There were a total of 411 Cochrane protocols published in
Issues 2 to 4, 2000 and Issue 1, 2001 of The Cochrane library.
After excluding 39 protocols 372 (90.5%) remained in our sample
(Figure 1). Of these protocols, 19.1% (71/372) were not published
as full Cochrane reviews at the time of this study while 80.9%
(301/372) were published in full. Only 33.2% (100/372) of the
reviews were subsequently updated.
Reasons for non-publication as final reviews included that the
protocol is still active in The Cochrane Library and a
corresponding review has never been conducted (52.1%, 37/71),
the review authors acknowledged that the review is incomplete but
no reason was provided (14.1%, 10/71), the protocol was
withdrawn due to out-datedness (12.7%, 9/71), the Cochrane
review authors lacked time or interest (9.9%, 7/71), the reviewers
experienced operational issues (e.g., the lead author changed jobs;
5.6%, 4/71), and the Cochrane Collaboration rejected the review
(2.8%, 2/71). Information about two protocols (2.8%) was not
provided after contacting the corresponding author of the review.
We contacted the corresponding author or CRG coordinator for
the 71 reviewsthat wereunpublished as of January2008 to determine
the stage that the review was at, as well as to inquire whether the
review was ever published elsewhere. Sixty-eight responses (96%)
were received. The review was incomplete (stage not reported,
52.9%, 36/68), complete but never published in Cochrane (10.3%,
7/68),a draft manuscript was compiled (8.8%,6/68),at the literature
search stage (7.4%, 5/68), in peer review (7.4%, 5/68), at the analysis
stage (5.8%, 4/68), and at the data abstraction stage (7.4%, 5/68).
Only 13.2% (9/68) of the reviews were published elsewhere, one of
which was published as a book chapter.
Cochrane protocol characteristics
The majority of the corresponding authors were based in the
United Kingdom (39.5%, 147/372), while 13.4% (50/372) were
based in Australia, 7.3% (27/372) in Canada, and 7.0% in the
United States (26/373; Table 1). The median number of authors
per protocol was 3 (range: 1–22). Almost 3% (10/372) of the
reviews had two published protocols. Approximately 7% (27/372)
of the protocols had two unique Cochrane identification numbers,
possibly indicating inconsistent editorial practices.
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experimental (e.g., randomized controlled trials) and quasi-
experimental (e.g., interrupted time series) primary studies
(96.2%, 358/372; Table 1). Almost 75% of the protocols reported
a planned primary outcome (73.7%, 274/372) and the median
number of planned primary outcomes per protocol was 1 (range:
1–22). When reported, the majority of the protocols planned to
include all languages (34.4%, 128/372) and assess for heteroge-
neity (75.8%, 282/372), yet only 20.2% (75/372) planned to assess
for publication bias.
A little over half of the protocols reported a funding source
(58.1%, 216/372; Table 1). This was predominantly a not-for-
profit funder (46.3%, 100/216); while 27.3% (59/216) reported
funding from a government agency and 23.6% (51/216) reported
joint government and not-for-profit funding. Few protocols
reported for-profit organization funding, which is a Cochrane
mandate [1] and few of the corresponding authors reported being
a healthcare provider (20.4%, 76/372).
Survival analysis
The median time to publication using the most recent substantive
amendment date was 2.4 years (range: 0.15 to 8.96 years; inter-
quartile range, IQR: 3.8 years; Figure 2). This was similar to the
sensitivity analysis (i.e., the version first published online date), which
was 2.24 years (range: 0.25 to 7.75 years; IQR: 3.7 years). Of the
variables chosen for the univariate analyses, four were significant
and entered into the multivariate analyses: having two protocols
(p=0.001); an updated review (p,0.0001), number of authors
(p=0.008); and number of primary outcomes (p=0.002). There
was also a trend towards significance for the language inclusion
variable (p=0.06). These five factors were subsequently used in
the Cox proportional hazard model (Table 2).
In the multivariate analyses only two of the variables were
significant. A shorter time to publication was associated with the
review being an update (hazard ratio, HR 1.80 [95% CI: 1.39,
2.33)] and a longer time to publication was associated with the
review having two published protocols (HR 0.33 [95% CI: 0.12,
0.90]; Table 2). Sensitivity analysis based on the version first published
online date produced similar results.
Discussion
We conducted a retrospective cohort study of Cochrane
protocols to provide data on the average time to publication of
Cochrane reviews and factors associated with their publication.
Our results indicate that for every four published Cochrane
reviews, one review remained unpublished based on one year of
Cochrane protocols. As Cochrane reviews are regarded as being
scientifically rigorous, this finding is disquieting. As a major
contributor to the systematic review literature, we believe that all
Cochrane protocols should be completed and published as
Figure 1. Study flow. The cohort included a total of 411 Cochrane protocols and 379 (90.5%) remained after excluding 39. Of these protocols,
19.1% (71/372) were never published as full Cochrane reviews while 80.9% (301/372) were published in full.
doi:10.1371/journal.pone.0003684.g001
Cochrane Protocol Cohort Study
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minority (13.2%) were published elsewhere, indicating a major loss
of information being publicly available, as well as wasted scarce
resources.
A little more than half (52.1%) of the unpublished reviews were
still active Cochrane protocols in The Cochrane Library. This
indicates a lack of consistency in the Cochrane Collaboration’s
editorial procedures, as some of the protocols were withdrawn due
Table 1. Cochrane review characteristics.
Item
Total: 372
Cochrane
reviews
Descriptive characteristics
Country of conduct: n (%)
United Kingdom 147 (39.5)
Australia and New Zealand 50 (13.4)
Canada 27 (7.3)
United States of America 26 (7.0)
Italy 14 (3.8)
Netherlands 12 (3.2)
Brazil 9 (2.4)
France 8 (2.2)
China 7 (1.9)
Denmark 7 (1.9)
South Africa 7 (1.9)
Spain 7 (1.9)
Other 38 (10.2)
Not reported 13 (3.4)
Population examined: n (%)
Neonates only 21 (5.6)
Children only 11 (3.0)
Adolescents only 1 (0.3)
Adults only 61 (16.3)
Women only 49 (13.2)
Men only 4 (1.1)
Elderly only 4 (1.1)
Children and adolescents 13 (3.5)
Children, adolescents and adults 2 (0.5)
Adolescents and adults 5 (1.3)
Adolescents, adults and elderly 1 (0.3)
All 200 (53.8)
Number of authors: median (range) 3 (1, 22)
Review had two protocols: n (%) 10 (2.7)
Review had two unique Cochrane identification numbers: n (%) 27 (7.3)
Methodological characteristics
Type of reports to be included in the reviews: n (%)
Observational only 0 (0)
Experimental and quasi-experimental only 358 (96.2)
Both 14 (3.8)
Number of databases to be searched: median (range) 4 (1, 22)
A primary outcome was reported: n (%) 274 (73.7)
Number of primary outcomes: median (range) 1 (1, 20)
Reviews with multiple primary outcomes: n (%)* 135 (49.3)
Language inclusion: n (%)
English only 6 (1.6)
Mixed languages only 5 (1.4)
All languages 128 (34.4)
Not reported 233 (62.6)
Publication bias was to be assessed: n (%) 75 (20.2)
Heterogeneity was to be assessed: n (%) 282 (75.8)
Other characteristics
Item
Total: 372
Cochrane
reviews
Gender of corresponding author: n (%)
Female 132 (35.5)
Male 192 (51.6)
Unclear 48 (12.9)
Corresponding author was a healthcare provider: n (%) 76 (20.4)
Number of reviews with funding: n (%) 216 (58.1)
Type of funding source: n (%){
Government only 59 (27.3)
Not-for-profit organization only 100 (46.3)
Insurance company only 1 (0.5)
Government and not-for-profit organization 51 (23.6)
For-profit organization and government 2 (0.9)
For-profit and government and not-for-profit 3 (1.4)
Notes:
* Denominator is number of reviews with a primary outcome (n=274),
{
denominator is published reviews (n=301),
{ denominator is number of reviews
with funding (n=216).
doi:10.1371/journal.pone.0003684.t001
Table 1. cont.
Figure 2. Kaplan-Meier Curve for the time to publication of
Cochrane reviews and 95% confidence intervals. The Kaplan-
Meier Curve displays that the proportion of unpublished Cochrane
reviews decreases over time.
doi:10.1371/journal.pone.0003684.g002
Cochrane Protocol Cohort Study
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inconsistency was the finding that 7% of the included protocols
had two unique identification numbers. The Cochrane Library is
unusual in that there is no single person directly responsible for its
quality assurance. We hope that with the appointment of the
Library’s new editor-in-chief, the number of unpublished Co-
chrane reviews will decrease substantially.
Our results indicated that the median time to publication of the
completed Cochrane review from the published protocol was
2.4 years, and some reviews took as long as 9 years to be published
(using the most recent substantive amendment date). Our results are
consistent with another study that examined the time to publication
from submission to final publication of the review [14]. However,
our time frame is double that reported elsewhere [15], as this study
examined a different time period than this study did [15].
In this study, a longer time to publication was associated with
the review having two protocols. Strategies to decrease time to
publication should be considered. These may include providing
support to reviewers when protocol changes occur and streamlin-
ing the publication process to decrease the time to publication of
Cochrane reviews [16].
As noted elsewhere, updating systematic reviews is of para-
mount importance because some health care interventions
currently known to be effective may be shown to be ineffective
or harmful in the future and new interventions or health outcomes
may emerge [17,18]. Our results indicate a shorter time to
publication associated with the review subsequently being
updated. This could be due to a variety of reasons, such as a
quickly evolving clinical content area or a highly motivated
Cochrane review team. A recent study examined indicators
predicting when systematic reviews go out of date [15]. These
analyses found that shorter time to update was associated with the
cardiovascular content area (i.e., indicating a quickly evolving
clinical area) and heterogeneity being present or suspected in the
review (i.e., indicating a motivation to examine unstable results).
The current Cochrane guidance is to update their reviews every
2 years [1]. Although our cohort spans over 8 years, only a third
of the reviews were updated and only 2 out of the entire sample
had 3 updates. For Cochrane reviews (as any other systematic
reviews) to maintain their currency, a more active policy should be
considered to ensure that a much higher proportion is kept up-to-
date. This could include international harmonization of aspects of
the updating process and having other authors finish the update
when too much time has elapsed.
The reasons for unpublished Cochrane reviews seem to be
different than the reasons for unpublished individual studies (e.g.,
trials). For clinical trials, there is a trend towards shorter time to
publication when they are sponsored by private industry (e.g.,
pharmaceutical companies) [9,11] and a higher likelihood of
publication when they are funded [19]. Our findings are consistent
with a recent survey on the publication practices of systematic
reviewers. In this survey, the most commonly reported reasons for
not publishing Cochrane reviews included lack of time, the
manuscript being rejected, and operational issues (Andrea Tricco
personal communication). Members of the investigative team are
currently involved with research exploring these issues.
This study has some limitations. Only one investigator
abstracted all of the data, which could have led to inaccuracies.
Furthermore, we did not examine all of the review factors
associated with the time to publication and the reasons for
publishing Cochrane reviews elsewhere often were not provided
by the review authors. However, our cohort includes one year of
data with a large number of Cochrane protocols, a high response
rate was attained for the 71 unpublished reviews, and two
investigators performed random data checks and resolved any
issues with the data. Furthermore, the Cochrane review factors
associated with the time to publication have been examined
elsewhere recently (Andrea Tricco, personal communication).
In conclusion, only about 80% of Cochrane protocols were
published as full reviews after more than 8 years of follow-up. The
median time to publication was nearly two and a half years and
some reviews took considerably longer. We recommend that the
Cochrane Collaboration have consistent editorial policies, stream-
line the review process to decrease the time to publication, provide
support for review authors when changes to the protocol occur,
and provide a better infrastructure for updating Cochrane reviews.
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Table 2. Factors predicting the time to publication of Cochrane reviews
Factor
Univariate Hazard
Ratio* (95% CI) p-value
Multivariate Hazard
Ratio* (95% CI) p-value
Language inclusion (including all vs. including mixed languages and not reported) 1.27 (1.00, 1.61) 0.04 1.31 (0.69, 2.50) 0.42
Language inclusion (not reported vs. reported) 0.78 (0.62, 0.98) 0.03 1.00 (0.52, 1.91) 0.10
Review has two published protocols vs. one published protocol 0.27 (0.10, 0.72) 0.01 0.33 (0.12, 0.90) 0.03
Number of primary outcomes reported in the protocol 1.05 (0.77, 1.44) 0.00 1.02 (0.98, 1.05) 0.23
Number of authors on the protocol 0.90 (0.84, 0.98) 0.01 0.94 (0.86, 1.03) 0.17
Review subsequently being updated 1.87 (1.47, 2.35) ,0.001 1.78 (1.39, 2.33) ,0.0001
Note:
* Hazard ratios indicate the relative hazard to the time to publication. Numbers above 1 indicate an decreased time to publication, numbers below 1 indicate an
increased time to publication.
Abbreviation: CI confidence interval.
doi:10.1371/journal.pone.0003684.t002
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